An optimized method for high-titer lentivirus preparations without ultracentrifugation

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Jiang, Wei ^a,b   Hua, Rui ^a,b   Wei, Mengping ^a,b   Li, Chenhong ^b   Qiu, Zilong ^c   Yang, Xiaofei ^b   Zhang, Chen ^a  

^a PEKING UNIVERSITY   (China)

^b SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES   (China)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BIOTECHNOLOGY; CELL LINE; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LENTIVIRINAE; METABOLISM; MOUSE; NERVE CELL; PROCEDURES; REPORTER GENE; ULTRACENTRIFUGATION; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; BIOTECHNOLOGY; CELL LINE; GENES, REPORTER; GENETIC VECTORS; HUMANS; LENTIVIRUS; MICE; NEURONS; TRANSDUCTION, GENETIC; ULTRACENTRIFUGATION; VIRAL LOAD; VIRUS REPLICATION;

EID: 84941046554     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13875     Document Type: Article

References (29)

1. Tang, H., Kuhen, K. L. & Wong-Staal, F. Lentivirus replication and regulation. Annu Rev Genet 33, 133-170 (1999).
2. Naldini, L. et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267 (1996).
3. Dull, T. et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 72, 8463-8471 (1998).
4. Kafri, T. Lentivirus vectors: difficulties and hopes before clinical trials. Curr Opin Mol Ther 3, 316-326 (2001).
5. Wong, L. F. et al. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications. Hum Gene Ther 17, 1-9 (2006).
6. Schambach, A. & Baum, C. Clinical application of lentiviral vectors-concepts and practice. Curr Gene Ther 8, 474-482 (2008).
7. Kumar, P. & Woon-Khiong, C. Optimization of lentiviral vectors generation for biomedical and clinical research purposes: contemporary trends in technology development and applications. Curr Gene Ther 11, 144-153 (2011).
8. Segura, M. M., Kamen, A. A. & Garnier, A. Overview of current scalable methods for purification of viral vectors. Methods Mol Biol 737, 89-116 (2011).
9. Schweizer, M. & Merten, O. W. Large-scale production means for the manufacturing of lentiviral vectors. Curr Gene Ther 10, 474-486 (2010).
10. Salmon, P. & Trono, D. Production and titration of lentiviral vectors. Curr Protoc Neurosci Chapter 4, Unit 4 21 (2006).
11. Tonini, T., Claudio, P. P., Giordano, A. & Romano, G. Transient production of retroviral-and lentiviral-based vectors for the transduction of Mammalian cells. Methods Mol Biol 285, 141-148 (2004).
12. Zufferey, R. Production of lentiviral vectors. Curr Top Microbiol Immunol 261, 107-121 (2002).
13. al Yacoub, N., Romanowska, M., Haritonova, N. & Foerster, J. Optimized production and concentration of lentiviral vectors containing large inserts. J Gene Med 9, 579-584 (2007).
14. Zhang, C. et al. Neurexins physically and functionally interact with GABA(A) receptors. Neuron 66, 403-416 (2010).
15. Azzouz, M. & Mazarakis, N. Non-primate EIAV-based lentiviral vectors as gene delivery system for motor neuron diseases. Curr Gene Ther 4, 277-286 (2004).
16. Delzor, A., Escartin, C. & Deglon, N. Lentiviral vectors: a powerful tool to target astrocytes in vivo. Curr Drug Targets 14, 1336-1346 (2013).
17. Dreyer, J. L. Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions. Mol Biotechnol 47, 169-187 (2011).
18. Teschemacher, A. G. et al. Targeting specific neuronal populations using adeno-and lentiviral vectors: applications for imaging and studies of cell function. Exp Physiol 90, 61-69 (2005).
19. Yamada, K., McCarty, D. M., Madden, V. J. & Walsh, C. E. Lentivirus vector purification using anion exchange HPLC leads to improved gene transfer. Biotechniques 34, 1074-1078, 1080 (2003).
20. Reiser, J. Production and concentration of pseudotyped HIV-1-based gene transfer vectors. Gene Ther 7, 910-913 (2000).
21. Semple, M., Loveday, C., Weller, I. & Tedder, R. Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapy. J Med Virol 35, 38-45 (1991).
22. Papanikolaou, E. et al. Characterization and comparative performance of lentiviral vector preparations concentrated by either one-step ultrafiltration or ultracentrifugation. Virus Res 175, 1-11 (2013).
23. Kutner, R. H., Zhang, X. Y. & Reiser, J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc 4, 495-505 (2009).
24. Nasri, M., Karimi, A. & Allahbakhshian Farsani, M. Production, purification and titration of a lentivirus-based vector for gene delivery purposes. Cytotechnology 66, 1031-1038 (2014).
25. Zimmermann, K. et al. Highly efficient concentration of lenti-and retroviral vector preparations by membrane adsorbers and ultrafiltration. BMC Biotechnol 11, 55 (2011).
26. Matsuoka, H., Miyake, K. & Shimada, T. Improved methods of HIV vector mediated gene transfer. Int J Hematol 67, 267-273 (1998).
27. Kohno, T. et al. A new improved method for the concentration of HIV-1 infective particles. J Virol Methods 106, 167-173 (2002).
28. Soler-Llavina, G. J., Fuccillo, M. V., Ko, J., Sudhof, T. C. & Malenka, R. C. The neurexin ligands, neuroligins and leucine-rich repeat transmembrane proteins, perform convergent and divergent synaptic functions in vivo. Proc Natl Acad Sci USA 108, 16502-16509 (2011).
29. Zhang, C. et al. Presenilins are essential for regulating neurotransmitter release. Nature 460, 632-636 (2009).